ng-nitroarginine methyl ester has been researched along with Coronary Artery Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktaş, SG; Atay, A; Çuhadar, S; Dursun, S; Köseoğlu, M | 1 |
| di Stolfo, G; Dragoni, S; Gori, T; Lisi, M; Liuni, A; Luca, MC; Mariani, JA; Parker, JD; Uxa, A | 1 |
| Cortese-Krott, MM; Feelisch, M; Heiß, C; Hogg, N; Horn, P; Kelm, M; Krenz, T; Krisp, C; Kröncke, KD; Kuhnle, GG; Rodriguez-Mateos, A; Sansone, R; Thasian-Sivarajah, S; Wolters, D | 1 |
| Horiuchi, M; Huang, PL; Morishita, T; Nakashima, Y; Sasaguri, Y; Suda, O; Tanimoto, A; Tasaki, H; Tsutsui, M; Yanagihara, N | 1 |
| Egashira, K; Hiasa, K; Ichiki, T; Inoue, S; Ishibashi, M; Kitamoto, S; Ni, W; Takeshita, A; Usui, M; Zhao, Q | 1 |
| Bidouard, JP; Malo, O; Perrault, LP; Vanhoutte, PM; Vilaine, JP; Villeneuve, N | 1 |
| Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR | 1 |
| Egashira, K; Fukumoto, Y; Kadokami, T; Kozai, T; Kuga, T; Kuwata, K; Shimokawa, H; Sueishi, K; Takeshita, A; Yonemitsu, Y | 1 |
| Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K | 1 |
| Hori, M; Hoshida, S; Kawahara, K; Kuzuya, T; Yamashita, N | 1 |
| Egashira, K; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takeshita, A; Takeya, M; Yoshimura, T | 1 |
| Egashira, K; Kataoka, C; Katoh, M; Kitamoto, S; Koyanagi, M; Narita, H; Ohmachi, Y; Takeshita, A; Usui, M | 1 |
12 other study(ies) available for ng-nitroarginine methyl ester and Coronary Artery Disease
| Article | Year |
|---|---|
The anti-inflammatory and antioxidant effects of pravastatin and nebivolol in rat aorta.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta; Ceruloplasmin; Cholesterol; Coronary Artery Disease; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Nebivolol; NG-Nitroarginine Methyl Ester; Pravastatin; Rats; Rats, Wistar; Triglycerides; Uric Acid | 2014 |
Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial function.
Topics: Adolescent; Adult; Analysis of Variance; Brachial Artery; Coronary Artery Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Regional Blood Flow; Smoking; Vasodilation | 2010 |
Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease.
Topics: Adult; Amino Acid Sequence; Arginine; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Endothelium, Vascular; Erythrocytes; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Immunoprecipitation; Mass Spectrometry; Microscopy, Confocal; Molecular Sequence Data; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxyhemoglobins; Sequence Alignment; Sequence Analysis, Protein; Sequence Homology, Amino Acid | 2012 |
Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
Topics: Acridines; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Coronary Artery Disease; Coronary Vessels; Cyclic GMP; Disease Progression; Luminescent Measurements; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Peptidyl-Dipeptidase A; Time | 2002 |
Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Glucose; Blood Pressure; Chemokine CCL2; Coronary Artery Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Inflammation; Insulin; Lipids; Male; Monocytes; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Pioglitazone; Rats; Rats, Inbred WKY; Receptors, CCR2; Receptors, Chemokine; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2002 |
Inhibiting the NO pathway with intracoronary L-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
Topics: Animals; Coronary Artery Disease; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Female; Graft Rejection; Heart Transplantation; Hyperplasia; Infusions, Parenteral; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Severity of Illness Index; Signal Transduction; Swine; Time Factors; Tunica Intima | 2003 |
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone | 2003 |
Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1beta in pigs in vivo.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Guanidines; Immunohistochemistry; Interleukin-1; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Swine; Vasoconstriction | 1997 |
Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous; Vena Cava, Inferior | 1998 |
Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arterial Occlusive Diseases; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Isoquinolines; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; P-Selectin; Peroxidase; Quinapril; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Ventricular Fibrillation | 1999 |
Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
Topics: Animals; Antibodies, Monoclonal; Blood Pressure; Cell Division; Chemokine CCL2; Chronic Disease; Collagen; Coronary Artery Disease; Dermis; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inflammation; Male; Monocytes; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2000 |
Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Apoptosis; Blood Pressure; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Enzyme Inhibitors; Imidazoles; Imidazolidines; In Situ Nick-End Labeling; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred WKY | 2001 |